Previous 10 | Next 10 |
2023-04-11 13:16:16 ET Gainers: Innovative Eyewear ( LUCY ) +157% . WW International ( WW ) +50% . Brenmiller Energy ( BNRG ) +45% . Brookdale Senior Living ( BKD ) +34% . ZeroFox Holdings ( ZFOX ) +31% . Kura Sushi USA ( K...
2023-04-11 10:02:34 ET Gainers: Innovative Eyewear ( LUCY ) +170% . Brookdale Senior Living ( BKD ) +20% . Apollomics ( APLM ) +16% . TG Therapeutics ( TGTX ) +16% . Butterfly Network ( BFLY ) +13% . Losers: GlucoTrac...
2023-04-10 16:57:48 ET Agile Therapeutics ( NASDAQ: AGRX ) said it had approved a 1-for-50 reverse stock split. The reverse stock split was approved by Agile’s stockholders on March 9, and will increase the per share trading price of the stock for the minimum bid price ...
PRINCETON, N.J., April 10, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women's healthcare company, today announced that its board of directors approved a 1-for-50 reverse stock split, to be effective 4:00 p.m. on Monday, April 10, 2023. The Com...
2023-03-24 12:31:48 ET The following slide deck was published by Agile Therapeutics, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Agile Therapeutics, Inc. 2022 Q4 - Results - Earnings Call Presentation
2023-03-24 12:31:03 ET Agile Therapeutics, Inc (AGRX) Q4 2022 Earnings Conference Call March 22, 2023 16:30 ET Company Participants Matt Riley - Head, Investor Relations Al Altomari - Chairman and Chief Executive Officer Amy Welsh - Chief Commercial Officer J...
2023-03-22 16:53:27 ET Agile Therapeutics press release ( NASDAQ: AGRX ): Q4 GAAP EPS of -$0.10 beats by $0.12 . Revenue of $4M (+164.9% Y/Y) beats by $0.87M . Shares +31.14% . For further details see: Agile Therapeutics GAAP EPS of -$0.10 beats b...
Fourth Quarter 2022 Net Revenue Increased 33% from Third Quarter 2022 While GAAP Quarter-Over-Quarter OPEX Decreased 55% and Non-GAAP OPEX Remained Unchanged Twirla Demand and Factory Sales Up 25% and 30% Respectively in Fourth Quarter 2022 vs Third Quarter 2022 Company Reaffirm...
PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 financial results after the market close on Wednesday, March 22, 2023. Following the release, the C...
Nasdaq has granted to the women's healthcare company Agile Therapeutics ( NASDAQ: AGRX ) a 180-day extension to regain compliance with the stock exchange's listing requirements. The company has until Aug. 14 to meet the requirement. The company was notified of its failure to maint...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
NASDAQ Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...